United Kingdom

N4 Pharma plc

Track

N4 Pharma plc records indicate that the most recent insider trading activity occurred on April 10, 2019. During this period, Chief Executive Officers Anne-Marie Lawrence and Nigel Theobald each purchased 67,343 shares, totaling 2,990.03 in value per individual. No further transactions have been reported by company insiders since that date.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Anne-Marie Lawrence Chief Executive Officer Officer
Through Anne-Marie Lawrence, a closely affiliated person
Transaction date
Purchase
Price
366.22
Quantity 19,456
Value £1,275,352
Nigel Theobald Chief Executive Officer Officer
Transaction date
Purchase
Price
127.01
Quantity 95,402
Value £1,885,026
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-04-10 2019-04-10 B Purchase Anne-Marie Lawrence

Chief Executive Officer

Through Anne-Marie Lawrence, a closely affiliated person Officer
19,456
366.22
£1,275,352 		19,456 366.22 £1,275,352
2019-04-10 2019-04-10 B Purchase Nigel Theobald

Chief Executive Officer

Officer
95,402
127.01
£1,885,026 		95,402 127.01 £1,885,026
Explore more

More insider trading research around N4 Pharma plc

More insider trades in United Kingdom
Insider trading in Europe